iNtRON Biotechnology, Inc. (KOSDAQ:048530)
3,710.00
+45.00 (1.23%)
Feb 19, 2026, 1:49 PM KST
-30.00% (1Y)
| Market Cap | 112.35B -38.9% |
| Revenue (ttm) | 5.56B -35.5% |
| Net Income | -6.29B |
| EPS | -197.47 |
| Shares Out | 30.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (2.73%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 144,648 |
| Average Volume | 318,861 |
| Open | 3,710.00 |
| Previous Close | 3,665.00 |
| Day's Range | 3,540.00 - 3,715.00 |
| 52-Week Range | 2,895.00 - 5,360.00 |
| Beta | 0.22 |
| RSI | 53.82 |
| Earnings Date | Jan 22, 2026 |